BACKGROUND: In obesity, which is a major contributor to insulin resistance and diabetes, the circulating level of S100A8/A9 (calprotectin) is elevated and declines after Roux-en-Y gastric bypass surgery (RYGB). However, studies on S100A8/A9 and the pathophysiological mechanisms in insulin resistance and diabetes are few and contradictory. METHODS: We studied 48 subjects who underwent RYGB, comprising a non-diabetic control group and two diabetic groups in whom diabetes either regressed or persisted, 6-12 months post-surgically. S100A8/A9, interleukin 6 (IL-6) as well as other inflammatory and diabetes-related markers were measured pre- and post-surgically. RESULTS: Significant and similar decreases of BMI were found in all groups. S100A8/A9 and IL-6 decreased significantly in the group with diabetes remission and in the control group, but not in the group with persistent diabetes. The relative changes in S100A8/A9 and IL-6 correlated significantly (r = 0.905, p = 0.005) only in the group with persistent diabetes. In contrast, leukocyte count and C-reactive protein correlated significantly to S100A8/A9 only in the control group. CONCLUSION: Our study is suggestive of S100A8/A9 and IL-6 being related to a persistent diabetes status post-surgically and of different pathophysiological mechanisms being involved in the post-surgical changes in the three groups, despite similar decreases in BMI.
BACKGROUND: In obesity, which is a major contributor to insulin resistance and diabetes, the circulating level of S100A8/A9 (calprotectin) is elevated and declines after Roux-en-Y gastric bypass surgery (RYGB). However, studies on S100A8/A9 and the pathophysiological mechanisms in insulin resistance and diabetes are few and contradictory. METHODS: We studied 48 subjects who underwent RYGB, comprising a non-diabetic control group and two diabetic groups in whom diabetes either regressed or persisted, 6-12 months post-surgically. S100A8/A9, interleukin 6 (IL-6) as well as other inflammatory and diabetes-related markers were measured pre- and post-surgically. RESULTS: Significant and similar decreases of BMI were found in all groups. S100A8/A9 and IL-6 decreased significantly in the group with diabetes remission and in the control group, but not in the group with persistent diabetes. The relative changes in S100A8/A9 and IL-6 correlated significantly (r = 0.905, p = 0.005) only in the group with persistent diabetes. In contrast, leukocyte count and C-reactive protein correlated significantly to S100A8/A9 only in the control group. CONCLUSION: Our study is suggestive of S100A8/A9 and IL-6 being related to a persistent diabetes status post-surgically and of different pathophysiological mechanisms being involved in the post-surgical changes in the three groups, despite similar decreases in BMI.
Authors: Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Fernando Rotellar; Victor Valentí; Camilo Silva; María J Gil; José Manuel Fernández-Real; Javier Salvador; Gema Frühbeck Journal: Mol Med Date: 2011-07-05 Impact factor: 6.354
Authors: Bárbara Dal Molin Netto; Solange Cravo Bettini; Ana Paula Grotti Clemente; Joana Pereira de Carvalho Ferreira; Katia Boritza; Sandy de Fátima Souza; Maria Emilia Von der Heyde; Carrie P Earthman; Ana R Dâmaso Journal: Obes Surg Date: 2015-06 Impact factor: 4.129
Authors: Jeroen Nijhuis; Sander S Rensen; Yanti Slaats; Francois M H van Dielen; Wim A Buurman; Jan Willem M Greve Journal: Obesity (Silver Spring) Date: 2009-04-23 Impact factor: 5.002
Authors: Filipe M Cunha; Ana Saavedra; José Barbosa; Paula Freitas; Davide Carvalho; Ana Varela Journal: Surg Obes Relat Dis Date: 2016-02-03 Impact factor: 4.734
Authors: Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg Journal: Cell Metab Date: 2013-05-07 Impact factor: 27.287
Authors: Panagiotis G Xenoulis; Romy M Heilmann; Eva M Stavroulaki; Denise S Riggers; Laura J Gneipel; Jan S Suchodolski; Jörg M Steiner Journal: J Vet Intern Med Date: 2022-04-21 Impact factor: 3.175
Authors: Michelle C Flynn; Gerard Pernes; Man Kit Sam Lee; Prabhakara R Nagareddy; Andrew J Murphy Journal: Front Pharmacol Date: 2019-06-13 Impact factor: 5.810
Authors: Bárbara María Varela-Rodríguez; Paula Juiz-Valiña; Luis Varela; Elena Outeiriño-Blanco; Susana Belén Bravo; María Jesús García-Brao; Enrique Mena; José Francisco Noguera; Javier Valero-Gasalla; Fernando Cordido; Susana Sangiao-Alvarellos Journal: J Clin Med Date: 2020-01-13 Impact factor: 4.241